Skip to main content

Advertisement

Table 1 Patients’ characteristics

From: Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer

  arm A (n = 25) arm B (n = 25) p-value
Sex    0.11
 Male 21 16  
 Female 4 9  
Age    0.81
 median 63 65  
 range 55-74 45-74  
Histology    0.69
 Adenocarcinoma 17 18  
 Large cell carcinoma 0 1  
 Squamous 6 5  
 Others 2 1  
Stage    0.56
 IIIB 10 8  
 IV 15 17  
PS    0.54
 0 9 6  
 1 16 19